B7-H4 Polymorphism Influences the Prevalence of Diabetes Mellitus and Pro-Atherogenic Dyslipidemia in Patients with Psoriasis.

MLA

Yang, Wenjing, et al. “B7-H4 Polymorphism Influences the Prevalence of Diabetes Mellitus and Pro-Atherogenic Dyslipidemia in Patients with Psoriasis.” Journal of Clinical Medicine, vol. 11, no. 21, Nov. 2022, p. 6235. EBSCOhost, https://doi.org/10.3390/jcm11216235.

APA

Yang, W., Huang, Q., Han, L., Wang, B., Yawalkar, N., Zhang, Z., & Yan, K. (2022). B7-H4 Polymorphism Influences the Prevalence of Diabetes Mellitus and Pro-Atherogenic Dyslipidemia in Patients with Psoriasis. Journal of Clinical Medicine, 11(21), 6235. https://doi.org/10.3390/jcm11216235

Chicago

Yang, Wenjing, Qiong Huang, Ling Han, Bing Wang, Nikhil Yawalkar, Zhenghua Zhang, and Kexiang Yan. 2022. “B7-H4 Polymorphism Influences the Prevalence of Diabetes Mellitus and Pro-Atherogenic Dyslipidemia in Patients with Psoriasis.” Journal of Clinical Medicine 11 (21): 6235. doi:10.3390/jcm11216235.